Atlas Trials

Impact of Treatment With Cytoreducing Agent

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Impact of Treatment With Cytoreducing Agent

RecordFirmDate
SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications (NCT04539678)Nantes University Hospital2019-05-21

Track Impact of Treatment With Cytoreducing Agent automatically

Every clearance here is in the API, with alerts when new ones post.